Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

New study finds semaglutide (or ‘Ozempic/Wegovy’) safe for brain health with possible benefits for cognition and nicotine dependence

General Research

Semaglutide – widely known as Ozempic or Wegovy – does not appear to negatively impact brain health and is associated with lower risk of cognitive problems and less nicotine dependence, according to a new study.

Yellowstone Biosciences spinout launches to advance cutting-edge cancer therapies

General MRC MHU MRC WIMM Research

Yellowstone Biosciences, a biotechnology spinout, has launched to pioneer new cancer treatments using advanced T-cell therapies based on groundbreaking research from the MRC Weatherall Institute of Molecular Medicine at the University of Oxford.

Senior Fellowship awarded to Costas Christodoulides

Awards General OCDEM

Congratulations to Costas Christodoulides, who has been awarded a Senior Clinical Research Fellowship with the British Heart Foundation.

Professor Rajesh Thakker receives OBE in King’s Birthday Honours

General OCDEM

Congratulations to RDM’s Professor Rajesh Vasantlal Thakker FRS, May Professor of Medicine and lately President, Society for Endocrinology, who has been appointed Officer of the Order of the British Empire (OBE) in the King’s Birthday Honours 2024.

RDM launches new metabolism cross-cutting research theme

General Research

On Monday 10 June, more than 50 members of RDM met to kick off the ‘Metabolism in Molecular Medicine’ cross-cutting research theme.

Heart scans could help thousands avoid unnecessary invasive procedure

CVM General Research

Thousands of patients admitted to hospital every year with suspected heart attacks could avoid an unnecessary invasive procedure if they have a routine heart MRI scan first, according to research led by the Radcliffe Department of Medicine.

AI analysis of routine heart scans can predict risk of a developing heart problems ten years in advance, new research finds

AMIIC CVM General Publication Research

A research team led by scientists at the Radcliffe Department of Medicine, University of Oxford has developed an Artificial Intelligence (AI) technology which can accurately predict the risk of a heart attack, heart failure or cardiac death from routine cardiac CT scans, up to ten years in advance.

Study outlines feasibility of multiple disease risk prediction model for primary care

CVM General OCMR Research

A team of researchers, led by the Radcliffe Department of Medicine, has found that a single, integrated health check carried out in a primary care setting can accurately predict risks for diseases across multiple organs.

New Fellow of the Academy of Medical Sciences

General MRC WIMM

Congratulations to Professor Adam Mead, who has been elected by the Academy of Medical Sciences to its fellowship.

Congratulations to our new Associate Professors

General

RDM is delighted to announce the conferment of three new Associate Professors. Each of our new Associate Professors has been awarded the title in recognition of their contributions to research, teaching and citizenship at the University and beyond.

Early blood glucose control for people with type 2 diabetes is crucial for reducing complications and prolonging life

DTU General Research

Research led by scientists from the Universities of Oxford and Edinburgh has found that early good blood glucose control can minimise the lifetime risk of diabetes-related complications, including heart attacks, kidney failure and vision loss.

Cancer Cell study identifies possible ways cancer treatment can lead to harmful side effects

General MRC TIDU MRC WIMM

Researchers from the Simmons and Koohy Groups in the Weatherall Institute of Molecular Medicine (WIMM) Translational Immune Discovery Unit have identified potential pathways by which cancer treatment can cause colitis.

The Radcliffe Department of Medicine mourns the sudden death of Professor Stephen Harrison

General

Friends and colleagues of Professor Stephen Harrison, at the Radcliffe Department of Medicine, where he was a visiting professor, are deeply saddened to hear about his untimely passing. Our thoughts are with his family and friends at this difficult time.

Immunology at the MRC Weatherall Institute of Molecular Medicine

General MRC WIMM

For International Day of Immunology 2024, three scientists from the MRC Translational Immune Discovery Unit in the Weatherall Institute of Molecular Medicine (WIMM) speak about their research.

Load More

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk